Company profile for UroGen Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

UroGen Pharma is a clinical-stage biopharmaceutical company developing advanced, minimally invasive treatments to address unmet needs in the field of urology, with a focus on uro-oncology. We have developed RTGel ™, a novel drug delivery technology platform, that is liquid when chilled, but gels at body temperature. We believe RTGel technology has the potential to be applied to a variety of unmet medical needs where increas...
UroGen Pharma is a clinical-stage biopharmaceutical company developing advanced, minimally invasive treatments to address unmet needs in the field of urology, with a focus on uro-oncology. We have developed RTGel ™, a novel drug delivery technology platform, that is liquid when chilled, but gels at body temperature. We believe RTGel technology has the potential to be applied to a variety of unmet medical needs where increased exposure to the active drug would improve the therapeutic profile of existing drugs while decreasing toxicity associated with systemic delivery, making local therapy a potentially more effective treatment option.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
499 Park Avenue, Suite 1200 New York, NY 10022
Telephone
Telephone
46-768-9780
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/05/3200660/0/en/UroGen-Pharma-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

GLOBENEWSWIRE
05 Dec 2025

https://www.medac-cdmo.com/news-events/newsroom/medac-cdmo-supports-urogen-pharma

PRESS RELEASE
27 Nov 2025

https://www.globenewswire.com/news-release/2025/11/25/3194255/0/en/UroGen-Pharma-to-Present-at-the-Piper-Sandler-37th-Annual-Healthcare-Conference.html

GLOBENEWSWIRE
25 Nov 2025

https://www.globenewswire.com/news-release/2025/11/06/3182531/0/en/UroGen-Reports-Third-Quarter-2025-Financial-Results-as-ZUSDURI-Launch-Gains-Momentum.html

GLOBENEWSWIRE
06 Nov 2025

https://www.globenewswire.com/news-release/2025/11/04/3180255/0/en/UroGen-Pharma-to-Present-at-Guggenheim-Securities-Healthcare-Innovation-Conference.html

GLOBENEWSWIRE
04 Nov 2025

https://www.globenewswire.com/news-release/2025/10/30/3177306/0/en/UroGen-Pharma-to-Report-Third-Quarter-2025-Financial-Results-on-Thursday-November-6th-2025.html

GLOBENEWSWIRE
30 Oct 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty